iShares Healthcare Innovation UCITS ETF USD (Acc) | HEALRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 47.4 | -5.2 | -14.0 | -3.7 | 4.3 | |
+/-Cat | 29.9 | -14.6 | -9.3 | -0.6 | -1.0 | |
+/-B’mrk | - | -23.4 | -19.8 | -1.1 | -3.8 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
Closing Price 24/04/2024 | USD 7.25 | |
Day Change | 1.04% | |
Morningstar Category™ | Sector Equity Healthcare | |
Volume | 8187 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | IE00BYZK4776 | |
Fund Size (Mil) 23/04/2024 | USD 1049.33 | |
Share Class Size (Mil) 23/04/2024 | USD 1049.33 | |
Ongoing Charge 31/01/2023 | 0.40% |
Investment Objective: iShares Healthcare Innovation UCITS ETF USD (Acc) | HEAL |
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the STOXX Global Breakthrough Healthcare Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 08/09/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
STOXX Global Breakthrough Healthcare | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for iShares Healthcare Innovation UCITS ETF USD (Acc) | HEAL | 22/04/2024 |
|
|
Top 5 Holdings | Sector | % |
Neurocrine Biosciences Inc | Healthcare | 2.04 |
UCB SA | Healthcare | 2.02 |
Boston Scientific Corp | Healthcare | 1.92 |
Catalent Inc | Healthcare | 1.83 |
Amgen Inc | Healthcare | 1.77 |
Increase Decrease New since last portfolio | ||
iShares Healthcare Innovation UCITS ETF USD (Acc) | HEAL |